Skip to content

Medical-device intelligence

SET: Immunoassay Blood Test For Amyloid Pathology Assessment

FDA product code SET: Immunoassay Blood Test For Amyloid Pathology Assessment. View classification details, related manufacturers, 510(k) clearances, and recall records.

FDA classification ↗

Classification details

Product code
SET
FDA device name
Immunoassay Blood Test For Amyloid Pathology Assessment
Device class
2
Regulation number
866.5840
Medical specialty
Immunology
Review panel
IM

FDA definition

An Immunoassay blood test for amyloid pathology assessment is an in vitro diagnostic test used to identify patients with amyloid pathology associated with Alzheimer’s Disease who have signs and symptoms of cognitive decline. The results of the test are to be interpreted in conjunction with other patient clinical information.
Explore immunology records →
A product code groups records by FDA classification. It does not establish identical intended uses, commercial availability, or comparative device safety.

Record activity in this scope

4 clearance records and 7 recall records in the covered releases, across 3 source company names and 1 product codes. Dated history runs from May 16, 2025 to Aug 19, 2026.

Monthly counts through October 2026
Month510(k) decisionsRecall initiations
October 202510
November 202500
December 202507
January 202600
February 202600
March 202600
April 202600
May 202600
June 202600
July 202600
August 202620
September 202600
October 202600

Product codes represented

Code and FDA device nameClearancesRecalls
SET · Immunoassay Blood Test For Amyloid Pathology Assessment47

All-history totals use the covered releases; monthly counts stop at the last calendar month covered by both sources. Clearances use decision dates; recalls use initiation dates. 0 records lack the required date and are excluded from monthly counts. These are records, not product launches, market share, incidence rates, or comparative safety. Feed filters below do not change this overview.

Clearances and recall records

11 matching records
Device / recordCompany in FDA recordSourceSource date
PrecivityAD2 TestK253240 · SETC2N Diagnostics, LLC510(k)Aug 19, 2026FDA decision date
Elecsys Phospho-Tau (217P) PlasmaK261686 · SETRoche Diagnostics510(k)Aug 19, 2026FDA decision date
Product Name: Lumipulse G pTau217/B-Amyloid 1-42 Plasma Ratio Model/Catalog Number: CL0073 Software Version: Not Applicable Product Description: …Z-1301-2026 · SETFujirebio Diagnostics, Inc.RecallFeb 5, 2026FDA classification date
Product Name: Lumipulse G pTau 217 Plasma Immunoreaction Cartridges Model/Catalog Number: 81550 Software Version: Not Applicable Product Descript…Z-1302-2026 · SETFujirebio Diagnostics, Inc.RecallFeb 5, 2026FDA classification date
Product Name: Lumipulse G pTau 217 Plasma Calibrators Model/Catalog Number: 81557 Software Version: Not Applicable Product Description: Lumipulse…Z-1303-2026 · SETFujirebio Diagnostics, Inc.RecallFeb 5, 2026FDA classification date
Product Name: Lumipulse pTau 217 Plasma Controls Model/Catalog Number: 81558 Software Version: Not Applicable Product Description: Lumipulse pTau…Z-1304-2026 · SETFujirebio Diagnostics, Inc.RecallFeb 5, 2026FDA classification date
Product Name: Lumipulse G -Amyloid 1-42-N Plasma Immunoreaction Cartridges Model/Catalog Number: 235447 Software Version: Not Applicable Product …Z-1305-2026 · SETFujirebio Diagnostics, Inc.RecallFeb 5, 2026FDA classification date
Product Name: Lumipulse G -Amyloid 1-42-N Plasma Calibrators Model/Catalog Number: 235454 Software Version: Not Applicable Product Description: L…Z-1306-2026 · SETFujirebio Diagnostics, Inc.RecallFeb 5, 2026FDA classification date
Product Name: Lumipulse -Amyloid Plasma Controls Model/Catalog Number: 81559 Software Version: Not Applicable Product Description: Lumipulse -Amy…Z-1307-2026 · SETFujirebio Diagnostics, Inc.RecallFeb 5, 2026FDA classification date
Elecsys Phospho-Tau (181P) PlasmaK252163 · SETRoche Diagnostics510(k)Oct 8, 2025FDA decision date
Lumipulse G pTau217/ß-Amyloid 1-42 Plasma RatioK242706 · SETFujirebio Diagnostics,Inc.510(k)May 16, 2025FDA decision date

Manufacturers in these records

Useful context

Device classifications

FDA dataset:

Last successful check: Nov 21, 2026

Source classifications may change.

510(k) clearances

FDA dataset:

Last successful check: Nov 21, 2026

FDA publishes this dataset monthly.

Recall records

FDA dataset:

Last successful check: Nov 21, 2026

FDA publishes this dataset weekly.

Keep this research moving.

Follow ten competitors and ten product codes. Get matching changes in your dashboard and a weekly brief, for $49/month.

Start a 14-day free trial ↗